Search company, investor...
Promedtek company logo



Loan | Alive

Total Raised


Last Raised

$680K | 3 yrs ago

About Promedtek

ProMedTek is developing Composite Therapy for problem wounds in the medical device technology market.

Headquarters Location


Scottsdale, Arizona, 85251,

United States

Missing: Promedtek's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Promedtek's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Promedtek

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Promedtek is included in 1 Expert Collection, including Medical Devices.


Medical Devices

3,088 items

Companies that have been granted at least 1 510(k) by the FDA since 2014. Companies tagged as #FDA510(K)

Promedtek Patents

Promedtek has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Diabetes, Vascular diseases, Medical treatments, Necrosis, Cardiovascular physiology


Application Date


Grant Date



Related Topics

Diabetes, Vascular diseases, Medical treatments, Necrosis, Cardiovascular physiology



Promedtek Frequently Asked Questions (FAQ)

  • Where is Promedtek's headquarters?

    Promedtek's headquarters is located at 7272 EAST INDIAN SCHOOL ROAD SUITE 102, Scottsdale.

  • What is Promedtek's latest funding round?

    Promedtek's latest funding round is Loan.

  • How much did Promedtek raise?

    Promedtek raised a total of $680K.

  • Who are the investors of Promedtek?

    Investors of Promedtek include Paycheck Protection Program and Clayton Associates.

  • Who are Promedtek's competitors?

    Competitors of Promedtek include ADVOS, Vapotherm, Game Ready, DFine, Celleration and 12 more.

Compare Promedtek to Competitors

Health Care Solutions

Respiratory and infusion therapy for patients at home. Acquired by Lincare Holdings, Inc.

Synapse Biomedical Logo
Synapse Biomedical

Synapse Biomedical (SBI) was founded to commercialize the NeuRx Diaphragm Pacing System (DPS) that has been developed over a twenty-year period at Case Western Reserve University and the University Hospitals of Cleveland. The innovative research performed at these institutions has led to significant advances in the state of the art of electrical stimulation for the treatment of chronic respiratory insufficiency.


Cardiola have designed a patented device, the m.pulse device designed to treat chronic heart failure (CHF), non-surgically, in a patient's home.

Aspire Medical

Aspire Medical is developing a new therapy for treating obstructive sleep apnea.


Traumatec offers a patented, non-invasive device to cool the brain

Sunlight Medical

Sunlight Medical is a medical technology company engaged in the development, manufacture, and marketing of medical devices for physician's offices and hospitals. The company aims to become a provider of technology-intensive solutions that enable primary care practitioners to deliver high quality care at an cost.Sunlight comprises research and development headquarters in Israel and regional subsidiaries in Europe, Asia, and the United States. Sunlight has established strong sales and distribution channels in the relevant markets within these regions and sold thousands of its units worldwide. Since it was founded in 1995, Sunlight has become a player in the global osteoporosis diagnosis market.Sunlight devices, with radiation-free, user-friendly technologies to provide services that fit physicians' needs, are marketed both to small practices and to hospitals. The products are very reliable, highly accurate, moderately priced, and offer a profitable business model.Sunlight's osteoporosis management products include Sunlight Omnisense' 7000S, a noninvasive quantitative-ultrasound device developed for quick, user-friendly assessment of fracture risk and osteoporosis management, and Sunlight Omnisense' 8000S, the world's only multi-site portable bone assessment device.Products for the pediatric market include Sunlight BonAge, a quantitative ultrasound device for accurate bone age evaluation to be released in 2003. Current pediatric products are Sunlight Omnisense' 7000P for monitoring bone development in children and adolescents and Sunlight PREMIER for bone assessment in premature babies.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.